Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 26, 2025 21:54 ET | Source: Grabar Law Office

Grabar Law Office Investigates Claims on Behalf of Shareholders of DoubleVerify Holdings, Inc. (NYSE: DV); NAPCO Securities Technologies, Inc. (NASDAQ: NSSC); Pacira Biosciences, Inc. (NASDAQ: PCRX); and Treace Medical Concepts, Inc. (NASDAQ: TMCI)

PHILADELPHIA, May 26, 2025 (GLOBE NEWSWIRE) -- DoubleVerify Holdings, Inc. (NYSE: DV): If you have held DoubleVerify Holdings, Inc. (NYSE: DV) shares since prior to November 10, 2023, and...
March 13, 2025 15:25 ET | Source: Portnoy Law

Pacira BioSciences, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; March 14, 2025 Deadline to file Lead Plaintiff Motion

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, March 13, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Pacira BioSciences, Inc....
January 31, 2025 16:52 ET | Source: Robbins LLP

PCRX Stockholders Should Contact Shareholder Rights Firm Robbins for Information About the Class Action Against Pacira BioSciences, Inc.

Robbins LLP is Investigating Allegations that Pacira BioSciences, Inc. (PCRX) Failed to Disclose its Lack of Patent Protection for Exparel
September 29, 2014 19:59 ET | Source: Robbins LLP

Robbins Arroyo LLP is Investigating the Officers and Directors of Pacira Pharmaceuticals, Inc. (PCRX) on Behalf of Shareholders

SAN DIEGO and PARSIPPANY, N.J., Sept. 29, 2014 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Pacira Pharmaceuticals,...